Literature DB >> 16699032

Gangliosides are essential for bovine adeno-associated virus entry.

Michael Schmidt1, John A Chiorini.   

Abstract

Recombinant adeno-associated viruses (AAV) are promising gene therapy vectors. We have recently identified a bovine adeno-associated virus (BAAV) that demonstrates unique tropism and transduction activity compared to primate AAVs. To better understand the entry pathway and cell tropism of BAAV, we have characterized the initial cell surface interactions required for transduction with BAAV vectors. Like a number of AAVs, BAAV requires cell surface sialic acid groups for transduction and virus attachment. However, glycosphingolipids (GSLs), not cell surface proteins, were required for vector entry and transduction. Incorporation of gangliosides, ceramide-based glycolipids containing one or more sialic acid groups, into the cytoplasmic cell membranes of GSL-depleted COS cells partially reconstituted BAAV transduction. The dependency of BAAV on gangliosides for transduction was further confirmed by studies with C6 cells, a rat glioma cell line that is deficient in the synthesis of complex gangliosides. C6 cells were resistant to transduction by BAAV. Addition of gangliosides to C6 cells prior to transduction rendered the cells susceptible to transduction by BAAV. Therefore, gangliosides are a likely receptor for BAAV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699032      PMCID: PMC1472156          DOI: 10.1128/JVI.02393-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  Multistep entry of rotavirus into cells: a Versaillesque dance.

Authors:  Susana López; Carlos F Arias
Journal:  Trends Microbiol       Date:  2004-06       Impact factor: 17.079

2.  Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness.

Authors:  J Moss; P H Fishman; V C Manganiello; M Vaughan; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

3.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

Review 4.  Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances.

Authors:  N S Radin; J A Shayman; J Inokuchi
Journal:  Adv Lipid Res       Date:  1993

5.  Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes.

Authors:  L D Cahan; J C Paulson
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

6.  Uptake pathway of polyomavirus via ganglioside GD1a.

Authors:  Joanna Gilbert; Thomas Benjamin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Multiple glycosphingolipids determine the tissue tropism of parvovirus B19.

Authors:  L L Cooling; T A Koerner; S J Naides
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

8.  Identification of PDGFR as a receptor for AAV-5 transduction.

Authors:  Giovanni Di Pasquale; Beverly L Davidson; Colleen S Stein; Inês Martins; Dominic Scudiero; Anne Monks; John A Chiorini
Journal:  Nat Med       Date:  2003-09-14       Impact factor: 53.440

9.  Improved inhibitors of glucosylceramide synthase.

Authors:  A Abe; J Inokuchi; M Jimbo; H Shimeno; A Nagamatsu; J A Shayman; G S Shukla; N S Radin
Journal:  J Biochem       Date:  1992-02       Impact factor: 3.387

Review 10.  Virus entry: molecular mechanisms and biomedical applications.

Authors:  Dimiter S Dimitrov
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  24 in total

1.  Viral gene transfer to developing mouse salivary glands.

Authors:  J C Hsu; G Di Pasquale; J S Harunaga; T Onodera; M P Hoffman; J A Chiorini; K M Yamada
Journal:  J Dent Res       Date:  2011-11-17       Impact factor: 6.116

Review 2.  The AAV vector toolkit: poised at the clinical crossroads.

Authors:  Aravind Asokan; David V Schaffer; R Jude Samulski
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

3.  Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6.

Authors:  Zhijian Wu; Edward Miller; Mavis Agbandje-McKenna; Richard Jude Samulski
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Coxsackievirus A24 variant uses sialic acid-containing O-linked glycoconjugates as cellular receptors on human ocular cells.

Authors:  Nitesh Mistry; Hirotoshi Inoue; Fariba Jamshidi; Rickard J Storm; M Steven Oberste; Niklas Arnberg
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 5.  Parvovirus glycan interactions.

Authors:  Lin-Ya Huang; Sujata Halder; Mavis Agbandje-McKenna
Journal:  Curr Opin Virol       Date:  2014-07-19       Impact factor: 7.090

6.  Enhanced sialic acid-dependent endocytosis explains the increased efficiency of infection of airway epithelia by a novel adeno-associated virus.

Authors:  David D Dickey; Katherine J D A Excoffon; James T Koerber; Jamie Bergen; Benjamin Steines; Julia Klesney-Tait; David V Schaffer; Joseph Zabner
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

7.  Recombinant adeno-associated virus vectors in the treatment of rare diseases.

Authors:  Eric Hastie; R Jude Samulski
Journal:  Expert Opin Orphan Drugs       Date:  2015-05-15       Impact factor: 0.694

8.  BAAV transcytosis requires an interaction with beta-1-4 linked- glucosamine and gp96.

Authors:  Giovanni Di Pasquale; Nikola Kaludov; Mavis Agbandje-McKenna; John A Chiorini
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

9.  Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942).

Authors:  Michael Schmidt; Lakshmanan Govindasamy; Sandra Afione; Nick Kaludov; Mavis Agbandje-McKenna; John A Chiorini
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

10.  Gene transfer using bovine adeno-associated virus in the guinea pig cochlea.

Authors:  S B Shibata; G Di Pasquale; S R Cortez; J A Chiorini; Y Raphael
Journal:  Gene Ther       Date:  2009-05-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.